Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

19.31 -1.00 (-4.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Here's Bill Gates' Top Artificial Intelligence Stock Other Than Microsoft -- and Wall Street Thinks It Can Soar Nearly 70% Over the Next 12 Months
Bill Gates is excited about AI. And he seems to really like the opportunities for this AI company. 
Via The Motley Fool
Topics Artificial Intelligence
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
From Schrödinger
Via Business Wire
7 Stocks the Big Money Is Buying Now
For an idea of which stocks the Big Money is buying, take a quick look at this list of seven hot stocks today. 
Via InvestorPlace
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
Here are just a few top biotech stocks that may be on the cusp of major, game-changing discoveries, thanks to AI. 
Via InvestorPlace
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
 
Via Benzinga
Why Shares of Schrödinger Are Falling Thursday
The company released second-quarter earnings after the markets closed on Wednesday. 
Via The Motley Fool
Why Is Schrödinger Stock Tumbling Today?
Schrödinger Inc (NASDAQ: SDGR) shares are down after the company, on Wednesday,  
Via Benzinga
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
 
Via Benzinga
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst
You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio. 
Via The Motley Fool
Topics Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
3 AI Stocks Billionaires Are Loading Up On
With investors pouring funds into AI, it makes sense to consider snapping up the top AI stocks billionaires buy. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday morning! 
Via InvestorPlace
Qualcomm, PayPal, Etsy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Schrödinger Reports Second Quarter 2023 Financial Results
From Schrödinger, Inc.
Via Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
 
Via Benzinga
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
They're not guaranteed to keep soaring, but they are right now. 
Via The Motley Fool
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Announce Second Quarter 2023 Financial Results on August 2
From Schrödinger, Inc.
Via Business Wire
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
Both companies could tap into huge growth from the AI revolution in a few years. 
Via The Motley Fool
This Artificial Intelligence Biotech Stock Is Crushing the Market, but Is It a Buy?
Its software platform could become a core tool for many businesses in biopharma. 
Via The Motley Fool
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
Cathie Wood's Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.